Comprehensive Cancer Center Support Grant

$69,669P30FY2025CANIH

University Of Alabama At Birmingham, Birmingham AL

Investigators

Linked publications, trials & patents

Paper 39713459 Paper 39642329 Paper 39604120 Paper 39553825 Paper 39489766 Paper 39464096 Paper 39386666 Paper 39377264 Paper 39361227 Paper 39323387 Paper 39255453 Paper 39240686 Paper 39218899 Paper 39199623 Paper 39149492 Paper 38956234 Paper 38948780 Paper 38935616 Paper 38918836 Paper 38867704 Paper 38849476 Paper 38824070 Paper 38772123 Paper 38766241 Paper 38743486 Paper 38570263 Paper 38539515 Paper 38530365 Paper 38518528 Paper 38467087 Paper 38451522 Paper 38277493 Paper 38262310 Paper 38250045 Paper 38241154 Paper 38154167 Paper 38150547 Paper 38150142 Paper 38135177 Paper 38114543 Paper 38106208 Paper 38086808 Paper 38068776 Paper 38039923 Paper 38011564 Paper 37946177 Paper 37931781 Paper 37919169 Paper 37895177 Paper 37892669 Paper 37850446 Paper 37782053 Paper 37776872 Paper 37717172 Paper 37660914 Paper 37643018 Paper 37640572 Paper 37626587 Paper 37578272 Paper 37552575 Paper 37495106 Paper 37483698 Paper 37479754 Paper 37428799 Paper 37398342 Paper 37398202 Paper 37384638 Paper 37382447 Paper 37380890 Paper 37365848 Paper 37345044 Paper 37327322 Paper 37287117 Paper 37246417 Paper 37240357 Paper 37226942 Paper 37192295 Paper 37177979 Paper 37142223 Paper 37067340 Paper 37058110 Paper 37046795 Paper 37046042 Paper 37034637 Paper 37014961 Paper 36968227 Paper 36958335 Paper 36926842 Paper 36922679 Paper 36907775 Paper 36904284 Paper 36900368 Paper 36882605 Paper 36865329 Paper 36775449 Trial NCT06247124 Trial NCT05871125 Trial NCT03713697 Trial NCT02839720 Patent 6743893

Abstract

PROJECT SUMMARY The primary purpose of the NCI Early Career Investigator Award (ECIA) is to support clinical investigators in the pursuit of a career in academic clinical trials and grow participation in NCI-sponsored trials at designated NCI cancer centers. The OâNeal Comprehensive Cancer center at the University of Alabama at Birmingham is the premier cancer center in Alabama and the surrounding regions. The proposed ECIA application is specifically designed to provide salary support for dedicated protected time to Dr. Charles Peyton, a urologic oncologist at UAB. As such, the protected time will be utilized with the following objectives to improve upon the genitourinary (GU) cancer service line at UAB. (1) Accelerate the growth of GU clinical trial portfolio, development and accrual at UAB, emphasizing NCI-sponsored clinical trials. Methods will include research infrastructure development, implementation design and expansion of clinical trial awareness institutionally and regionally. (2) Increase cross departmental and multi-institutional collaborative engagements with UAB through NCI designated avenues and clinical trial opportunities. Methods include scheduled collaborative meetings and attendance of NCI designated collaborative networking and task force groups. Line item, achievable goals will be designed, executed and audited. (3) Elevate the ECIA recipient as an institutional clinical trial leader. Methods will provide Dr. Peyton with time dedicated to participating in institutional clinical trial leadership. Achieving these strategic objectives will elevate the UAB GU cancer service line to a collaborative, multifaceted leading clinical trial group, providing cutting-edge clinical trials to Alabama and the Southeast United States.

View original record on NIH RePORTER →